SEARCH SITE
VIRGINIA LAW PORTAL
- Code of Virginia
- Virginia Administrative Code
- Constitution of Virginia
- Charters
- Authorities
- Compacts
- Uncodified Acts
- RIS Users (account required)
SEARCHABLE DATABASES
- Bills & Resolutions
session legislation - Bill Summaries
session summaries - Reports to the General Assembly
House and Senate documents - Legislative Liaisons
State agency contacts
ACROSS SESSIONS
- Subject Index: Since 1995
- Bills & Resolutions: Since 1994
- Summaries: Since 1994
Developed and maintained by the Division of Legislative Automated Systems.
2016 SESSION
SB 513 Prescription Monitoring Program; requirements of prescribers of opiates.
Introduced by: Siobhan S. Dunnavant | all patrons ... notes | add to my profiles
SUMMARY AS PASSED SENATE: (all summaries)
Prescription Monitoring Program; requirements of prescribers of opioids. Requires a prescriber to obtain information from the Prescription Monitoring Program at the time of initiating a new course of treatment that includes the prescribing of opioids anticipated to last more than 14 consecutive days. Currently, a prescriber must request such information when a course of treatment is expected to last 90 days. The bill also eliminates the requirement that a prescriber request information about a patient from the Prescription Monitoring Program when prescribing benzodiazepine; allows a prescriber to delegate the duty to request information from the Prescription Monitoring Program to another licensed, registered, or certified health care provider who is employed at the same facility under the direct supervision of the prescriber or dispenser who has routine access to confidential patient data and has signed a patient data confidentiality agreement; and creates an exemption from the requirement that a prescriber check the Prescription Monitoring Program for cases in which (i) the opioid is prescribed to a patient currently receiving hospice or palliative care; (ii) the opioid is prescribed to a patient as part of treatment for a surgical procedure, provided that such prescription is not refillable; (iii) the opioid is prescribed to a patient during an inpatient hospital admission or at discharge; (iv) the opioid is prescribed to a patient in a nursing home or a patient in an assisted living facility that uses a sole source pharmacy; (v) the Prescription Monitoring Program is not operational or available due to temporary technological or electrical failure or natural disaster; or (vi) the prescriber is unable to access the Prescription Monitoring Program due to emergency or disaster and documents such circumstances in the patient's medical record. The bill requires the Director of the Department of Health Professions to report to the House Committee on Health, Welfare and Institutions and the Senate Committee on Education and Health on utilization of the Prescription Monitoring Program and any impact on the prescribing of opioids. The provisions of the bill expire on July 1, 2019. This bill is identical to HB 293.
FULL TEXT
- 01/13/16 Senate: Prefiled and ordered printed; offered 01/13/16 16103620D pdf | impact statement
- 02/04/16 Senate: Committee substitute printed 16104979D-S1 pdf | impact statement
- 02/08/16 Senate: Floor substitute printed 16105228D-S2 (Dunnavant) pdf | impact statement
- 02/23/16 Senate: Bill text as passed Senate and House (SB513ER) pdf | impact statement
- 03/01/16 Governor: Acts of Assembly Chapter text (CHAP0113) pdf
HISTORY
- 01/13/16 Senate: Prefiled and ordered printed; offered 01/13/16 16103620D
- 01/13/16 Senate: Referred to Committee on Education and Health
- 02/04/16 Senate: Reported from Education and Health with substitute (14-Y 0-N)
- 02/04/16 Senate: Committee substitute printed 16104979D-S1
- 02/05/16 Senate: Constitutional reading dispensed (39-Y 0-N)
- 02/08/16 Senate: Read second time
- 02/08/16 Senate: Reading of substitute waived
- 02/08/16 Senate: Committee substitute rejected 16104979D-S1
- 02/08/16 Senate: Floor substitute printed 16105228D-S2 (Dunnavant)
- 02/08/16 Senate: Reading of substitute waived
- 02/08/16 Senate: Substitute by Senator Dunnavant agreed to 16105228D-S2
- 02/08/16 Senate: Engrossed by Senate - floor substitute SB513S2
- 02/09/16 Senate: Read third time and passed Senate (40-Y 0-N)
- 02/11/16 House: Placed on Calendar
- 02/11/16 House: Read first time
- 02/11/16 House: Referred to Committee on Health, Welfare and Institutions
- 02/18/16 House: Reported from Health, Welfare and Institutions (21-Y 0-N)
- 02/19/16 House: Read second time
- 02/22/16 House: Read third time
- 02/22/16 House: Passed House BLOCK VOTE (100-Y 0-N)
- 02/22/16 House: VOTE: BLOCK VOTE PASSAGE (100-Y 0-N)
- 02/23/16 Senate: Enrolled
- 02/23/16 Senate: Bill text as passed Senate and House (SB513ER)
- 02/23/16 Senate: Signed by President
- 02/23/16 House: Signed by Speaker
- 02/23/16 Senate: Enrolled Bill Communicated to Governor on 2/23/16
- 02/23/16 Governor: Governor's Action Deadline Midnight, March 1, 2016
- 03/01/16 Governor: Approved by Governor-Chapter 113 (effective 7/1/16)
- 03/01/16 Governor: Acts of Assembly Chapter text (CHAP0113)